GGrantIndex
Sort

8,912 grants matching sars cov 2

Adjuvant combination for SARS-CoV-2 vaccine for the elderly

$195,625
Elena Vassilieva · Emory University · R21 · FY2023 · AI

Mechanism of membrane inactivation method to prepare enveloped virus vaccines

$195,501
Hector Aguilar-Carreno · Cornell University · R21 · FY2022 · AI

Project 4

$195,438
Stanley Perlman · University Of Iowa · P01 · FY2017 · AI

Collaborative Research: Environmental Fate and Impacts of Quaternary Ammonium Compounds Following Increased Use During the SARS-CoV 2 Pandemic

$195,361
Patrick McNamara · Marquette University · · FY2021 · ENG

Novel long noncoding RNAs in the airway mucous response

$195,353
Madepalli Krishnappa Lakshmana · Florida International University · R21 · FY2020 · AI

East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium

$195,343
Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2025 · AI

Supplement: Exploring the biology of O-acetyl sialic acids using stable synthetic mimics

$195,234
Xi Chen · University Of California At Davis · R01 · FY2020 · AI

Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)

$195,200
Juan C Salazar · Connecticut Children'S Medical Center · R61 · FY2022 · HD

Psychological and Epigenetic Predictors of Obesity & Metabolic Disease

$195,156
Zachary Mathias Harvanek · Yale University · K23 · FY2025 · DK

Evaluating Teen-Parent Dynamics in Adolescent COVID-19 Vaccine Acceptance and Uptake

$195,117
Annette Karena Regan · University Of San Francisco · R21 · FY2022 · HD

RAPID: Scenario Projections for Seasonal Influenza, SARS-CoV-2 and RSV Burden in the US (2023-2024)

$195,101
Lauren A Meyers · University Of Texas At Austin · · FY2023 · BIO

Psychological and Epigenetic Predictors of Obesity & Metabolic Disease

$195,036
Zachary Mathias Harvanek · Yale University · K23 · FY2024 · DK

Admin-Core-001

$195,001
Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2022 · CA

Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2

$195,001
Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2022 · CA

Probing the particle size-viability relationship in bioaerosols through size-controlled measurements

$195,000
Hui Ouyang · University Of Texas Dallas · R21 · FY2025 · AI

Immunoproteasome-Mediated Inflammation in Coronavirus Respiratory Infection

$195,000
Jason Brice Weinberg · University Of Michigan At Ann Arbor · R21 · FY2023 · AI

A New Population-scale Approach for the Study of Psychological Stress in the Transition to Adulthood

$195,000
William G. Axinn · University Of Michigan At Ann Arbor · R21 · FY2022 · HD

The effect of Social Isolation on Lexical Retrieval in Elderly Adults

$195,000
Amy Victoria Vogel-Eyny · Hunter College · R21 · FY2023 · AG

COVID-19 related inflammation as a risk factor for age-related cognitive decline and Alzheimer's Disease

$195,000
Natalie Celia Tronson · University Of Michigan At Ann Arbor · R21 · FY2024 · AG

Structure-Function Analysis of Human and Bat Coronavirus Spike Proteins

$195,000
Krishna M.g. Mallela · University Of Colorado Denver · R21 · FY2025 · AI

Modifying Remdesivir Prodrug Design to Enhance the Active Metabolite Accumulation in the Lung (Resubmission)

$195,000
Haojie Zhu · University Of Michigan At Ann Arbor · R21 · FY2023 · AI

Durability of immune responses to SARS-CoV-2 infection in the context of HIV-infection, aging and cross-reactive immune responses.

$195,000
Beth D. Jamieson-Karavodin · University Of California Los Angeles · R01 · FY2020 · AG

A general, virus-free platform to rapidly map SARS-CoV-2 drug resistance

$195,000
Amit Choudhary · Broad Institute, Inc. · R21 · FY2022 · AI

Dissecting SARS-CoV-2 infection in Down syndrome with congenital heart defects using patient-specific iPSCs

$195,000
Mingtao Zhao · Research Inst Nationwide Children'S Hosp · R21 · FY2023 · HL

MHC class II immunopeptidomics analysis of the SARS-CoV-2 proteome

$195,000
Robert Lochhead · Medical College Of Wisconsin · R21 · FY2022 · AI